Silk Way West targets pharma following GDP achievement
25 / 06 / 2021
Silk Way West Airlines has been certified to Good Distribution Practice (GDP) standards as it takes aim at the pharma market.
The Baku-based B747 operator said that it had successfully completed an in-depth GDP audit by Global Cold Chain Consultants.
“Being GDP certified, Silk Way West Airlines now intends to extend its product line in transportation of medical goods and pharmaceutical logistics services,” the carrier said.
To reach the standard, Silk Way West Airlines’ internal procedures were upgraded in accordance with GDP principles, and the company’s entire staff were appropriately trained.
“Moreover, the carrier conducted a thermal mapping of its fleet and the extensive temperature-controlled storage facilities at its main hub in Baku to ensure the integrity of these processes. As a result, staff, equipment, and facilities are all aligned to deliver superior performance,” Silk Way West added.
Wolfgang Meier, chief executive and president of Silk Way West Airlines said: “Obtaining the GDP certification proves the readiness of Silk Way West Airlines in taking a leading role in global distribution of medical supplies.”
Good Distribution Practice (GDP) is a standard based on principles adopted by the European Union and recommended by the World Health Organization. In line with these requirements, medicines are to be obtained from a licensed supply chain and stored, transported and handled under suitable conditions.
